Tag: Dr. André Choulika

Cellectis begins MELANI-01 clinical trial for UCARTCS1 in multiple myeloma

pharmanewsdaily- October 30, 2019

Cellectis said that it has dosed the first patient in a phase 1  study - the MELANI-01 clinical trial to evaluate UCARTCS1, an allogeneic off-the-shelf ... Read More